News
4d
The Punch on MSNSickle cell and risk of blood clotsSickle Cell Disease is a chronic, inherited blood disorder that affects millions of people worldwide. It is best known for ...
Hyderabad: The Thalassemia & Sickle Cell Society (TSCS) has on Tuesday conducted a Continuing Medical Education (CME) ...
A Bahrain study shows CT scans to check for blood clots in lung blood vessels increased significantly in people with sickle ...
4d
First Alert 4 on MSNImpactLife, Dr. Charles Drew Blood Drive held Saturday in St. PetersImpactLife and the Theta Mu Nu Chapter of Omega Psi Phi fraternity are holding a blood drive on Saturday in St. Peters to ...
Overview of the Bone Marrow Transplantation MarketBone marrow transplantation market, also referred to as hematopoietic stem ...
The Michigan Sickle Cell Data Collection Program has been tracking information from the estimated 4,000 Michigan residents who suffer from sickle cell since 2020, but Trump administration cuts have ...
Free sickle cell trait screenings are making a difference in Jefferson County where students and health officials say testing ...
Enrollment is complete for the first groups of sickle cell patients taking pociredir and enrollment has begun for the 20 mg ...
Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET ...
Clayton County's community car show focuses on solidarity and social awareness, featuring cause-themed patrol cars.
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results